FDA gives early-use authorization to Lilly’s new COVID-19 antibody

Please subscribe to IBJ to decode this article.

grnlsewr yd ehhgesiaLvs1ctus Iasn o ie ftr slne9CwaaEeianlitioorfa t nsuz unka w sdra.win ntoivmcnDhoi oat t-ytyio ar.t oC ntaa Onkdnomrio lehoV haayl b r o

oosc alneeoFiV. orTdoDizeU Oaavoed f rrh nr s n siSr, rroard ao ghn eroasriene1Fiulnshh reub,lr oab- rotisi svtigohe2 . d f ys ielungi rbnkaet faaotd .diidoven s hooon1a indrnuaiaalulohlctgt9e eeoo ndgtppwvC m adlhiIfnminottaeteiepalDtetg,z Ahpd

lrruei.iwtsytibfde oifl atsiciberabi,d etd i n,sofimynee noT hannephshw

m7oha.tskhia- em -Tslttf0etd/epykonvdew sw$/ard-sstrofnowa.tu-un ogh npa0lno tn-0e0dafelpel iao le u>.ioiuyntedo-aetoa/lu dw ekolhl sd-miaagebato-hyh0n y i iir1n 2--.t a zve tabldlfei"geeeot

asie tnieihatItt evumascc fiUynsprii do idt rrenepDboho Olabre lvnosctm.oepfoen nsaelmwtoas y onntebLont.eeermtidt1pd edv whntla rondae tSCb vI fi.mteipalotay riv,itgks s’vi.neauha earoinhgemeyoiidg eebr,oab t stm9ceeho-D tlim,aiiti id d e .tdehcteeVs L i,t isbInneyt tantrts T aag lieu ddbaaf e fisrnhdrrov eo ’aha

nfeparto,de eeacn cihro.d sidsi n bgeteihtdUo daterfiee r lnebtunsanieutscag ivw gisaarpnieitgetfn fo ev teiuittsi htt s itlenndev edet pcsehkio, s e onnef v e omarne rrz

ospedr-yanoediheo. g ibllzlsinao-mfdooe>hnuw/are:uwaotwtaahrsdtrctukaFirw fylm   ycaeediap mh ograga ekth e"nrfbn thsnltj>tdoews uu rewdo"cv.tomAurt na-dthyl ul/h-c d

h.ttstbsctddtcvT iadoe Sh uh ed i piat aarhygashdriratt reenyte ng dhl efwtinehtied mitcnfene arsa,loiUhgimseuktri toyet nn t tnei s naarvstm ronam noi ttrecaeiae

hns. farir r ei n t“lsaorkuovthtt dnitsmuienlsearlnyeiooar Tign f y adaithhta rsiconnd orlLa esneegirnoe p asAnaavrt nnhlco t”msda, sgl nb ot,wOitu baaoc.tiaiarrwncnhottticd eaa g tno gsone rt2issl lw,itea t s eihhit naoaBenrftibeneztnn

o r yrwaaoasnd she0tfa3 ai0e n np5d1 tth oisro3oal,.l inn dhesdtlo ieefrou6ee0gt0tadevJcnhooM pni ore l,ey sml eftu0T,sla luoant cr0y ppt00a0 l t 0h h1

eub r-umn vorpnf eesmn usllbneiobwa8 vr tr mart b2 il i l%ata estpatvaguos. or alse yaa iu$s rnsenir da 4teeeeryl,cefreat edsoeltyreLfeieo tlaldllniagk qi aln ot tfb.crunatas isgoleidah2-n,u

p&b ;ns